Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
During the April 26th RECOVER Research Review (R3) Seminar, researchers presented on COVID-19 in children, including MIS-C (multi-inflammatory syndrome in children). Presenters discussed what is known about this topic, the gaps in our knowledge, and how RECOVER will contribute to filling these gaps.
During the April 12th RECOVER Research Review (R3) Seminar, researchers presented on commonalities between ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and PASC. Presenters discussed what is known about these disorders, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
This publication describes the study plan RECOVER researchers follow when answering questions about how Long COVID affects people aged 18 years and older.
During the May 22nd RECOVER Research Review (R3) Seminar, researchers presented on the clinical spectrum of PASC in both adults and children. Researchers discussed patient experiences with Long COVID, PASC in children, and an overview of PASC.
During the March 1st RECOVER Research Review (R3) Seminar, researchers presented on the epidemiology of PASC in both adults and children. Presenters discussed what is known about PASC epidemiology, the gaps in our knowledge, and how RECOVER will contribute to filling those gaps.
The federal government will consider Long COVID a disability if the condition or its symptoms “substantially limit” major life activities, such as work or school.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.